Bacterial Disease Diagnostics Market Analysis

Type (Bacterial Skin Infections, Sexually Transmitted Infections, Foodborne Infections)

The bacterial skin infections segment in the bacterial disease diagnostics market is estimated to gain the largest revenue share of about 45% in the year 2036. The growth of the segment can be attributed to the rising skin problem among the people. Skin is the most exposed part of the body, therefore many people get affected by acne, infection, and allergies caused by bacterial growth. Acne is the 8^th most common disease in the world and affects around 9% of the total global population.

End User (Hospitals, Labs, Research Centers)

Bacterial disease diagnostics market from hospital segment is expected to garner a significant share of around 40% in the year 2036. Hospitals play a significant part in patient care, and good diagnostic procedures are key for guiding treatment plans, improving patient outcomes, and limiting infection spread. Furthermore, the governments of various countries are increasing the budget for setting up hospital infrastructures, which is expected to drive the growth of the segment.

Our in-depth analysis of the global market includes the following segments:

Type	Bacterial Skin Infections Sexually Transmitted Infections Foodborne Infections
Product	Consumables Instruments
Technology	Isothermal Nucleic Acid Amplification Technology Polymerase Chain Reaction DNA Microarray Immunodiagnostics
End User	Hospitals Labs Research Centers

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of bacterial disease diagnostics is estimated at USD 3.46 Billion.

The bacterial disease diagnostics market size was valued at USD 3.23 Billion in 2023 and is set to cross USD 8.59 Billion by the end of 2036, expanding at more than 7.8% CAGR during the forecast period i.e., between 2024-2036. Increasing cases of bacterial infection and technological advancement in diagnostic technology are the major factors driving the market growth.

North America industry is projected to be the largest with a share of about 35% by 2036, due to rising instances of fatal infections caused by bacteria in the region.

bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, GENERI BIOTECH s.r.o.

Bacterial Disease Diagnostics Market Analysis